R
Recludix Pharma
Biotechnology📍 Cambridge, MA
Recludix Pharma develops novel SH2 domain inhibitors targeting STAT3 and STAT6 for cancer and inflammatory diseases.
Open Positions at Recludix Pharma
0 positions available
No open positions at the moment
Check back later for new opportunities!